[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,181
Citations 0
Editorial
February 2015

Introducing the Clinical Evidence Synopsis Section

Author Affiliations
  • 1Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
  • 2editor, JAMA Dermatology
  • 3Division of Dermatology, Department of Medicine, University of Louisville, Louisville, Kentucky
  • 4associate editor, JAMA Dermatology
JAMA Dermatol. 2015;151(2):127. doi:10.1001/jamadermatol.2014.1924

Harmonization of types of articles across the 10 journals of The JAMA Network provides an opportunity for JAMA Dermatology to adopt formats that were very well received by readers of other journals. JAMA led the development of the clinical evidence synopsis with the intention of providing a clinically relevant brief review of evidence-based guidelines and systematic reviews. The extensive evidence-based reviews done by organizations such as the Cochrane Collaboration, the US Preventive Services Task Force, and US National Institutes of Health Consensus Conferences will be searched for topics relevant to practicing dermatologists. The authors of the original review are invited to submit a 2-page synopsis. The Clinical Evidence Synopsis section will be published 4 times a year. In this issue, we present the first article, “Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp.”1

April W. Armstrong, MD, MPH, leads the Clinical Evidence Synopsis section. Dr Armstrong will be assisted by Daihung Do, MD, and Victoria R. Sharon, MD, DTMH. The focus of the editors is to frame the findings of the organization performing the review in ways that are relevant to practicing dermatologists and their patients. This section joins the Practice Gap section in interpreting and informing our readers about the evolution of knowledge and best practices recommendations in ways that will improve the care of our patients.

Please let us know if we fulfill our mission and suggest evidence-based reviews for the consideration of the editorial team of the Clinical Evidence Synopsis section.

April W. Armstrong, MD, MPH

Daihung Do, MD

Victoria R. Sharon, MD, DTMH

Back to top
Article Information

Corresponding Author: June K. Robinson, MD, Editor, JAMA Dermatology, Department of Dermatology, Feinberg School of Medicine, Northwestern University, 132 E Delaware Pl, Ste 5806, Chicago, IL 60611 (june.robinson@jamanetwork.org).

Published Online: January 28, 2015. doi:10.1001/jamadermatol.2014.1924.

References
1.
Kastarinen  H, Okokon  EO, Verbeek  JH.  Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp: summary of a Cochrane Review [published online January 28, 2015]. JAMA Dermatol. doi:10.1001/jamadermatol.2014.3186.
×